Journal
JOURNAL OF IMMUNOLOGY
Volume 183, Issue 11, Pages 7388-7397Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0902294
Keywords
-
Categories
Funding
- Leukemia Research Fund U.K [05096]
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- BBSRC [BBS/E/B/0000C236] Funding Source: UKRI
- MRC [MC_U117512793] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C236] Funding Source: researchfish
- Medical Research Council [MC_U117512793] Funding Source: researchfish
Ask authors/readers for more resources
Ribosomal protein S6 (rpS6) is a key component of the translational machinery in eukaryotic cells and is essential for ribosome biogenesis. rpS6 is phosphorylated on evolutionarily conserved serine residues, and data indicate that rpS6 phosphorylation might regulate cell growth and protein synthesis. Studies in cell lines have shown an important role for the serine kinase mammalian target of rapamycin (mTOR) in rpS6 phosphorylation, further linking rpS6 to control of cellular metabolism. rpS6 is essential in T cells because its deletion in mouse double-positive thymocyte cells results in a complete block in T cell development; however, the signaling pathway leading to rpS6 phosphorylation downstream of TCR stimulation has yet to be fully characterized. We show that maximal TCR-induced rpS6 phosphorylation in CD8 T cells requires both Lck and Fyn activity and downstream activation of PI3K, mTOR, and MEK/ERK MAPK pathways. We demonstrate that there is cross-talk between the PI3K and MAPK pathways as well as PI3K-independent mTOR activity, which result in differential phosphorylation of specific rpS6 serine residues. These results place rpS6 phosphorylation as a point of convergence for multiple crucial signaling pathways downstream of TCR triggering. The Journal of Immunology, 2009, 183: 7388-7397.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available